Ray JG. Oral potentially malignant disorders: Revisited. J Oral Maxillofac Pathol 2017;21(3):326-7. https://doi.org/10.4103/jomfp.JOMFP_224_17

Amagasa T, Yamashiro M, Uzawa N. Oral premalignant lesions: from a clinical perspective. Int J Clini Oncol 2011;16(1):5-14. https://doi.org/10.1007/s10147-010-0157-3

Mortazavi H, Baharvand M, Mehdipour M. Oral potentially malignant disorders: an overview of more than 20 entities. J Dent Res Dent Clin Dent Prospects 2014;8(1):6. https://doi.org/10.5681/joddd.2014.002

Speight PM, Khurram SA, Kujan O. Oral potentially malignant disorders: risk of progression to malignancy. J Dent Res Dent Clin Dent Prospects 2018;125(6):612-27. https://doi.org/10.1016/j.oooo.2017.12.011

Ganly I, Patel S, Shah J. Early stage squamous cell cancer of the oral tongue—clinicopathologic features affecting outcome. Cancer 2012;118(1):101-11. https://doi.org/10.1002/cncr.26229

Carmeliet P, Jain RK. Molecular mechanisms and clinical applications of angiogenesis. Nature 2011;473(7347):298-307. https://doi.org/10.1038/nature10144

Orsenigo F, Giampietro C, Ferrari A, Corada M, Galaup A, Sigismund S, et al. Phosphorylation of VE-cadherin is modulated by haemodynamic forces and contributes to the regulation of vascular permeability in vivo. Nature Commun 2012;3(1):1-15. https://doi.org/10.1038/ncomms2199

Hashimoto T, Soeno Y, Maeda G, Taya Y, Aoba T, Nasu M, et al. Progression of oral squamous cell carcinoma accompanied with reduced E-cadherin expression but not cadherin switch. PLoS One 2012;7(1):e47899. https://doi.org/10.1371/journal.pone.0047899

Hazan RB, Qiao R, Keren R, Badano I, Suyama K. Cadherin switch in tumor progression. Ann N Y Acad Sci 2004;1014(1):155-63. https://doi.org/10.1196/annals.1294.016

Yardimci G, Kutlubay Z, Engin B, Tuzun Y. Precancerous lesions of oral mucosa. World J Clin Cases 2014;2(12):866. https://doi.org/10.12998/wjcc.v2.i12.866

Srivastava R, Sharma L, Pradhan D, Jyoti B, Singh O. Prevalence of oral premalignant lesions and conditions among the population of Kanpur City, India: A cross-sectional study. J Fam Med Primary Care 2020;9(2):1080-5. https://doi.org/10.4103/jfmpc.jfmpc_912_19

Dissemond J. Oral lichen planus: an overview. J Dermatological Treat 2004;15(3):136-40. https://doi.org/10.4103/0975-7406.155873

Cepowicz D, Zaręba K, Pryczynicz A, Dawidziuk T, Żurawska J, Hołody-Zaręba J, et al. Blood serum levels of E-cadherin in patients with colorectal cancer. Gastroenterol Rev 2017;12(3):186-91. https://doi.org/10.5114/pg.2017.70471

Zuo JH, Zhu W, Li MY, Li XH, Yi H, Zeng GQ, et al. Activation of EGFR promotes squamous carcinoma SCC10A cell migration and invasion via inducing EMT‐like phenotype change and MMP‐9‐mediated degradation of E‐cadherin. J Cell Biochem 2011;112(9):2508-17. https://doi.org/10.1002/jcb.23175

Pai K, Baliga P, Shrestha BL. E-cadherin expression: a diagnostic utility for differentiating breast carcinomas with ductal and lobular morphologies. J Clin Diagn Res 2013;7(5):840-4. https://doi.org/10.7860/JCDR/2013/5755.2954

Al Kassam D, Blanco I, de Los Toyos J, Llorente J. Diagnostic value of E-cadherin, MMP-9, activated MMP-13 and anti-p53 antibodies in squamous cell carcinomas of head and neck. Med Clin 2007;129(20):761-5. https://doi.org/10.1157/13113764

López-Verdín S, de la Luz Martínez-Fierro M, Garza-Veloz I, Zamora-Perez A, Grajeda-Cruz J, González-González R, et al. E-Cadherin gene expression in oral cancer: Clinical and prospective data. Med Oral Patologia Oral Cirugia Bucal 2019;24(4):e444. https://doi.org/10.4317/medoral.23029